Navigation Links
Multiple ICD Replacements Can Predict Complications
Date:12/11/2008

Those with history of repeat surgeries likely to face infection, bleeding, study finds

THURSDAY, Dec. 11 (HealthDay News) -- Patients with implantable cardioverter defibrillators (ICDs) who've had multiple, previous pocket procedures have an increased risk of suffering complications after ICD replacement, according to a study that included the 12 largest ICD implanting centers in Canada.

Dr. Andrew Krahn, of the London Health Sciences Center in Ontario, and colleagues also found a higher-than-expected overall ICD replacement complication rate than previous studies.

The Canadian study included 451 patients who had ICD devices replaced between October 2004 and October 2005 and were monitored for major and minor complications. Major complications include serious infection requiring removal of the ICD, bleeding, or ICD malfunction. Minor complications include minor infection and worsening of other medical conditions.

After one year of follow-up, 41 (9.1 percent) of the patients experienced complications, 27 (5.9 percent) required additional surgery, and two patients died. Fourteen patients (3.1 percent) experienced minor complications.

The study, published in the December issue of HeartRhythm Journal, proves that multiple, previous pocket procedures are a predictor of ICD replacement complications, the researchers said.

"No prior research has investigated the potential risk factors associated with ICD replacement, more specifically, what makes some patients more at-risk than others," Krahn said in a Heart Rhythm Society news release. "Study findings will help physicians better understand complication risks for patients who may need ICD replacement, and ultimately, provide better care for their patients."

More information

The U.S. National Heart, Lung, and Blood Institute has more about '/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Drug combination improves or stabilizes disease for relapsed multiple myeloma patients
2. Researchers & Department of Defense Question Multiple Vaccine Administration
3. Brooks Kushman Stomps on Multiple Sclerosis: Local Law Firm Honored by Multiple Sclerosis Society for Fundraising Efforts
4. Insurers Employ Multiple Solutions to Avoid Radiology Expense Spike
5. National Multiple Sclerosis Society New Jersey Metro Chapter Looking for People to Join the Movement
6. Multiple sclerosis progression can be predicted with MRI
7. Multiple Sclerosis Association of Americas Resource Detectives(SM) Program Marks One Year Anniversary
8. Venables Election Watch Group Assesses Presidential Elections Impact on Multiple Industries
9. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
10. Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
11. Nanomedical approach targets multiple cancer genes, shrinks tumors more effectively
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Multiple ICD Replacements Can Predict Complications
Multiple ICD Replacements Can Predict Complications
Breaking Medicine News(10 mins):Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 2Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 5Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 2Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Fastrack Announces Major Expansion 2Health News:Fastrack Announces Major Expansion 3
Breaking Medicine Technology:Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4Springer launches SpringerImages 9172 1Springer launches SpringerImages 9172 2Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 1Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 2American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 1American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 2American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 3
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3